Compositions and methods for increasing bone mineralization

US9791462B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9791462-B2
Application numberUS-201514626274-A
CountryUS
Kind codeB2
Filing dateFeb 19, 2015
Priority dateNov 27, 1998
Publication dateOct 17, 2017
Grant dateOct 17, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A novel class or family of TGF-β binding proteins is disclosed. Also disclosed are assays for selecting molecules for increasing bone mineralization and methods for utilizing such molecules.

First claim

Opening claim text (preview).

We claim: 1. A method for identifying a candidate molecule capable of inhibiting binding of a protein encoded by SEQ ID NO: 1 to bone or an analogue thereof, comprising: combining, in vitro, a candidate molecule and a protein encoded by SEQ ID NO: 1 in the presence of bone or an analogue thereof; and detecting whether the candidate molecule inhibits the binding of the protein to bone or an analogue thereof. 2. The method according to claim 1 , wherein said analogue of bone is hydroxyapatite.

Assignees

Inventors

Classifications

  • cell-free systems · CPC title

  • against material from animals or humans · CPC title

  • Animals comprising random inserted nucleic acids (transgenic) · CPC title

  • for joint disorders, e.g. arthritis, arthrosis · CPC title

  • Polymorphic or mutational markers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9791462B2 cover?
A novel class or family of TGF-β binding proteins is disclosed. Also disclosed are assays for selecting molecules for increasing bone mineralization and methods for utilizing such molecules.
Who is the assignee on this patent?
Ucb Pharma Sa, Ucb Pharma Sa
What technology area does this patent fall under?
Primary CPC classification C07K14/51. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).